ELV
NYSE · Health Care
Elevance Health Inc
$296.09
+5.76 (+1.98%)
Performance
1D
—
1W
—
1M
—
3M
-15.37%
6M
-7.38%
1Y
-31.23%
YTD
-16.42%
Open$296.78
Previous Close$290.33
Day High$299.88
Day Low$289.30
52W High$458.75
52W Low$273.71
Volume—
Avg Volume2.64M
Market Cap63.73B
P/E Ratio11.26
EPS$25.11
SectorHealth Care
Technical Indicators
Full analysis →
SMA 50
$351.68
Below
SMA 200
$341.74
Below
RSI (14)
51
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
28 analysts
Price Target
-54.1% upside
Current
$296.09
$296.09
Target
$135.77
$135.77
$112.32
$135.77 avg
$190.73
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 195.07B | 180.05B | 28.12B |
| Net Income | 5.55B | 4.61B | 3.74B |
| Profit Margin | 2.8% | 2.7% | 13.3% |
| EBITDA | 8.56B | 7.51B | 6.88B |
| Free Cash Flow | — | — | 2.63B |
| Rev Growth | +8.3% | +8.3% | +22.0% |
| Debt/Equity | 0.73 | 0.73 | 0.47 |
Dividend
Dividend Yield2.40%
Annual Dividend$6.82
Payout Ratio27.0%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Recent Insider Activity
All Insiders →| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21 | DeVore Susan D. | Buy | 3,502 | $312.15 | $1.09M |
| Jul 18 | BOUDREAUX GAIL | Buy | 144,854 | $286.07 | $41.44M |
| Jul 18 | BOUDREAUX GAIL | Buy | 149,970 | $287.12 | $43.06M |
| Jul 18 | BOUDREAUX GAIL | Buy | 151,020 | $287.96 | $43.49M |
| Apr 25 | Kaye Mark | Sale | 18,977 | $424.82 | $8.06M |
About Elevance Health Inc
Elevance Health, Inc., formerly Anthem, is one of the largest health benefits companies in the United States, headquartered in Indianapolis, Indiana. The company provides health insurance and related services through affiliated health plans operating under the Blue Cross Blue Shield association and other brands. Elevance serves millions of members across commercial and specialty, government, and international markets through employer-sponsored plans, individual coverage, Medicare, and Medicaid programs. The company also operates Carelon, which provides pharmacy benefits management, behavioral health services, and care delivery solutions to improve health outcomes and affordability.
Health Care Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| UNH | UnitedHealth Group Inc | $270.55 | -0.64% | 21.7 | 261.12B |
| ABT | Abbott Laboratories | $104.83 | +0.74% | 28.3 | 184.68B |
| ISRG | Intuitive Surgical Inc | $469.98 | -0.41% | 59.8 | 170.78B |
| SYK | Stryker Corp | $327.65 | -0.26% | 39.5 | 128.28B |
| MDT | Medtronic Plc | $87.89 | +1.51% | 24.1 | 111.30B |
| MCK | Mckesson Corp | $879.75 | -0.25% | 25.1 | 109.03B |
ELV Frequently Asked Questions
What does Elevance Health Inc do?
Elevance Health is fundamentally in the business of managing healthcare costs and risk for millions of Americans. It collects premiums from employers, individuals, and government programs, then pays claims while keeping the spread — a model that rewards effective care management and network contracting. Its Carelon subsidiary adds a services layer, providing pharmacy benefits management and behavioral health services that help control medical costs. The company's Blue Cross Blue Shield licenses give it established, trusted brand recognition across most of its commercial markets.
Is ELV stock a good investment?
Elevance is one of the largest managed care companies in the U.S., with scale advantages in negotiating provider rates and managing risk pools. The stock has historically traded at a reasonable multiple relative to earnings growth, appealing to investors who want healthcare exposure with more predictability than hospital or biotech stocks. The central risk in recent years has been Medicaid margin pressure — as states adjust enrollment and reimbursement rates post-pandemic, medical cost ratios have become harder to forecast, creating earnings uncertainty that has weighed on the sector.
Who are Elevance Health Inc's main competitors?
UnitedHealth Group is the dominant force in U.S. managed care, competing with Elevance across commercial, Medicare Advantage, and Medicaid lines. Cigna and CVS Health (Aetna) compete heavily in employer-sponsored commercial insurance and pharmacy benefits. Centene and Molina Healthcare are more focused on government-sponsored Medicaid and marketplace plans, where they overlap with Elevance's government segment. For Medicare Advantage specifically, Humana is a major rival with a large and loyal senior membership base.
Does Elevance Health Inc pay dividends?
Elevance Health pays a regular quarterly dividend that has grown consistently over the years, reflecting the company's cash generation from its insurance operations. While the yield is modest relative to income-focused sectors, the company supplements dividends with share buybacks as the primary vehicle for returning capital. Managed care companies tend to be disciplined capital allocators, and Elevance's payout history reflects steady commitment to rewarding shareholders without overextending in a regulated industry.
How much does ELV stock cost right now?
ELV last closed at $296.09, up 1.98% in the most recent trading session. Over the past 52 weeks, the stock has traded between a low of $273.71 and a high of $458.75. The current price represents 12% of its 52-week range, which helps investors gauge where the stock sits relative to its recent trading history.
What is the analyst consensus for ELV?
Among 28 analysts covering ELV, the consensus rating is Hold — 15 rate it a buy, 13 hold, and 0 sell. The average price target sits at $135.77, implying 54% downside from the current price. Keep in mind that analyst targets reflect 12-month expectations and can shift quickly after earnings reports or major company events.
Does Elevance Health Inc make money?
Elevance Health Inc generated $195.07B in revenue during fiscal year 2026, with $5.55B reaching the bottom line as net income. The net profit margin of 2.8% reflects the competitive nature of its industry.
Is ELV stock expensive based on earnings?
ELV trades at a P/E ratio of 11.26 on trailing earnings of $25.11 per share. That's below the S&P 500 average, suggesting the market may see limited growth or is pricing in sector-specific risks. Comparing this multiple against Health Care sector peers gives better context than the broad market alone, since P/E norms vary significantly across industries.
Is ELV stock going up or down?
Performance varies across timeframes, reflecting shifting market conditions. Returns by timeframe: -15.37% (3M), -7.38% (6M), -31.23% (1Y), -16.42% (YTD). Comparing these figures against the S&P 500 and sector benchmarks helps determine whether ELV is outperforming or lagging the broader market.